贝莱特生物 BLTE
$154.19 +$11.00 (+7.68%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $154.19 0.00%
开盘$144.50
昨收$143.19
当日区间$141.00 – $155.80
成交量174.5K
市值$6.21B
市盈率（TTM）–
股息率–
财报
财报日平均波动±3.7%近14次财报
收涨次数10 / 1471% 的概率
最佳反应+8.9%
最差反应-9.9%
每次财报后次日股价变动
| 季度 | 财报日期 | 时段 | 隐含波动 | 实际波动 | 较隐含波动 |
|---|---|---|---|---|---|
| 2026/Q2 | 13 Aug 2026 | After Market | – | -2.09% | – |
| 2026/Q1 | 20 May 2026 | None | – | +0.62% | – |
| 2025/Q4 | 2 Mar 2026 | After Market | – | -5.46% | – |
| 2025/Q3 | 10 Nov 2025 | After Market | – | -9.87% | – |
| 2025/Q2 | 11 Aug 2025 | After Market | – | +4.65% | – |
| 2025/Q1 | 14 May 2025 | After Market | – | +8.88% | – |
| 2024/Q4 | 17 Mar 2025 | After Market | – | +0.84% | – |
| 2024/Q3 | 12 Nov 2024 | After Market | – | +1.33% | – |
| 2024/Q2 | 12 Aug 2024 | After Market | – | +3.73% | – |
| 2024/Q1 | 14 May 2024 | After Market | – | +1.07% | – |
| 2023/Q4 | 12 Mar 2024 | After Market | – | -2.61% | – |
| 2023/Q2 | 9 Aug 2023 | After Market | – | +6.24% | – |
| 2022/Q4 | 31 Mar 2023 | None | – | +1.36% | – |
| 2022/Q2 | 10 Aug 2022 | None | – | +3.54% | – |
"隐含波动"指财报发布前期权市场定价的预期波幅。"波动"指财报发布后首个交易日的股价变化。
基本面
最新报告季度：Q2, ended Jun 2026
营收$0.00
营业利润-$34.91M-98.4% YoY
净利润-$28.41M-74.1% YoY
摊薄每股收益-$0.70-40.0% YoY
自由现金流-$10.56M-129.3% YoY
经营现金流-$10.39M
营收，近8个季度
净利润，近8个季度
盈利能力与资产负债表
净资产收益率-22.1%
资产收益率-21.6%
投入资本回报率-22.1%
负债/资产比率1.9%
暂无评论——快来第一个聊聊 BLTE。